PRED FORTE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pred Forte, and when can generic versions of Pred Forte launch?
Pred Forte is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in PRED FORTE is prednisolone acetate. There are eighty-eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the prednisolone acetate profile page.
Summary for PRED FORTE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Patent Applications: | 3,861 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for PRED FORTE |
What excipients (inactive ingredients) are in PRED FORTE? | PRED FORTE excipients list |
DailyMed Link: | PRED FORTE at DailyMed |
Pharmacology for PRED FORTE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for PRED FORTE
US Patents and Regulatory Information for PRED FORTE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | PRED FORTE | prednisolone acetate | SUSPENSION/DROPS;OPHTHALMIC | 017011-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |